On November 21, Gary Beauchamp, director and president of the Monell Chemical Senses Center in Philadelphia, will be in Spain to discuss his well-known discovery of the oleocanthal molecule, a key component responsible for some of the heralded health benefits of extra virgin olive oil.
Similar to the nonsteroidal anti-inflammatory (NSAID) known as ibuprofen, oleocanthal shares the same anti-inflammatory properties but without the side effects of the medicine so widely employed by the pharmacy industry. Oleocanthal will be explained by the man who discovered it accidentally more than a decade ago.
Several studies after Beauchamp’s discovery found that oleocanthal could help remove the proteins that are the main component (known as beta-amyloid) of the amyloid plaques in Alzheimer patients.
Long-term consumption of small quantities of oleocanthal from olive oil may be responsible in part for the low incidence of heart disease and Alzheimer’s disease associated with a Mediterranean diet.
In fact, Beauchamp discovered oleocanthal during an experiment to improve the taste of ibuprofen.
While researching molecular gastronomy with a team of scientists, food specialists and chefs, Beauchamp was conducting an olive oil tasting when he noticed some similarities between the taste of a particular olive oil and the ibuprofen.
Invited by the Oleocanthal Society of Andalucia, QVExtra International and the Spanish Olive Oil Municipalities Association, Beauchamp will give a talk titled ‘Oleocanthal: a thrilling discovery’ at the Council of Córdoba to explain the process which took him to discover the molecule in olive oil that could help improve the lives of many.
Related Articles
Dec. 10, 2024
Regenerating Soil Helps Tackle Water Crisis, Experts Say
Specialists suggest agronomic plans to improve organic fertility, limit erosion and save water.
Dec. 5, 2024
Trump Health Secretary Pick Elevates Seed Oil Controversy to U.S. Cabinet
Robert F. Kennedy Jr. has long railed against seed oils. If confirmed as the Secretary of Health and Human Services, he will be in a position to regulate the industry.
Jan. 3, 2024
Researchers Develop Algorithm to Predict Harvest Potential from Climate Data
The publicly available algorithm was developed using 15 years of data from Italy to compare how combinations of climatic events impacted subsequent harvests.
Nov. 13, 2024
Early Intervention with EVOO Shows Promise in Reducing Down Syndrome Symptoms
New research in mice suggests that extra virgin olive oil consumption could mitigate neurodegenerative effects caused by Downs syndrome.
Jan. 15, 2024
Oleocanthal: Behind the Health Benefits of Olive Oil's Famous Phenol
Found solely in extra virgin olive oil, oleocanthal demonstrates potent anti-inflammatory properties and has been linked to beneficial impacts on cancer and dementia.
Oct. 18, 2024
Small Study Suggests Anti-Aging Potential of Polyphenols on Skin
Oleocanthal and oleacein significantly reduced wrinkle count in both men and women.
Dec. 2, 2024
IUCN Studies the Tradeoffs Between Intensive and Traditional Olive Groves
The organization found that traditional groves are better for biodiversity but less profitable. Intensive groves are more cost-efficient but create massive monocultures.
Aug. 13, 2024
Olive Center to Host Inaugural Olive Oil Sustainability Conference
The International Olive Sustainability Conference will discuss sustainability, from farming and milling to marketing and certifications.